Cogent Biosciences, Inc. (COGT)

NASDAQ: COGT · Real-Time Price · USD

15.13

+0.29 (1.95%)

At close: Oct 24, 2025, 4:00 PM EDT

15.19

+0.06 (0.39%)

After-hours: Oct 24, 2025, 7:14 PM EDT

Cogent Biosciences Employees

Cogent Biosciences had 205 employees as of December 31, 2024. The number of employees increased by 41 or 25.00% compared to the previous year.

Employees

205

Change (1Y)

41

Growth (1Y)

25.00%

Revenue / Employee

n/a

Profits / Employee

-$1,385,737

Market Cap

2.11B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	205	41	25.00%
Dec 31, 2023	164	26	18.84%
Dec 31, 2022	138	61	79.22%
Dec 31, 2021	77	62	413.33%
Dec 31, 2020	15	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

COGT News

2 days ago - Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
6 days ago - Cogent Biosciences Announces FDA Breakthrough Therapy Designation for Bezuclastinib - GlobeNewsWire
27 days ago - Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
7 weeks ago - Cogent Biosciences, Inc. (COGT) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
2 months ago - Cogent Biosciences Announces Participation in the Citi Biopharma Conference - GlobeNewsWire
2 months ago - Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results - GlobeNewsWire
3 months ago - Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
3 months ago - Cogent: Positive Data In NonAdvSM Bodes Well For 2nd Half AdvSM Treatment Results - Seeking Alpha